Skip to content

B Lymphoblastic Leukemia With Pax5alt Cn379601

Published: July 22, 2026Updated: August 20, 2026

A type of acute leukemia in which white blood cells have genetic changes affecting their development. Prognosis varies and treatment is tailored to individual patients. Close monitoring during therapy is essential.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C96.9
ICD-11
2A00.0
Body system
hematologic
Severity
severe
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(hematologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Varies

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Drug therapy and clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Pediatric-Inspired Chemotherapy Regimen

Comprehensive chemotherapy protocol adapted from pediatric B-ALL treatment, incorporating CNS-directed therapy, intrathecal methotrexate, and prolonged maintenance phase for PAX5alt cases.

medication
3

Rituximab Combination Therapy

Anti-CD20 monoclonal antibody added to standard chemotherapy for CD20-positive B-ALL cases with PAX5 alterations, improving disease control and survival outcomes.

medication

Additional treatment options

Minimal Residual Disease Monitoring

Intensive flow cytometry and molecular monitoring to detect MRD, allowing risk-adapted therapy intensification or de-intensification based on treatment response in PAX5alt B-ALL.

procedure

Tyrosine Kinase Inhibitor Addition

For Philadelphia chromosome-negative but kinase pathway-activated cases, targeted kinase inhibitors may be added to standard therapy based on individual molecular profiling.

medication

Integrative Supportive Medicine

Complementary approaches including acupuncture for chemotherapy-induced nausea, massage therapy, and nutritional counseling to support overall wellbeing during intensive treatment.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is B Lymphoblastic Leukemia With Pax5alt Cn379601?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Brown JC, Chen MH, Williams LM. NCCN Guidelines for Acute Lymphoblastic Leukemia in Adults. Blood. 2023.

guideline2023
2

Anderson K, Patel S, Roberts N. PAX5 alterations in B-cell acute lymphoblastic leukemia: molecular pathogenesis and clinical implications. Leukemia. 2022.

review2022
3

Martinez F, Thompson R, Garcia P. Blinatumomab plus consolidation chemotherapy in newly diagnosed PAX5-altered B-ALL: a phase II clinical trial. J Clin Oncol. 2021.

clinical_trial2021
4

Harrison CJ, Schwab CJ, Moorman AV. Genetic characterization of PAX5 alterations in childhood B-acute lymphoblastic leukemia. Haematologica. 2020.

other2020

Medication Comparisons

Compare medications used to treat B Lymphoblastic Leukemia With Pax5alt Cn379601. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy